Glyburide
Product Images NDC 75834-203

4 FDA label images from Nivagen Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 75834-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Glyburide 01)

Chemical Structure (Glyburide 01)
Chemical structure diagram of glyburide, showing its molecular arrangement including aromatic rings, chlorine, methoxy group, urea, sulfonyl, and cyclohexyl components.*
FDA Label Image

Principal Display Panel (1.25 mg Tablet Bottle Label)

Principal Display Panel (1.25 mg Tablet Bottle Label)
Label for GlyBURIDE Tablets, USP 1.25 mg by Nivagen Pharmaceuticals, Inc., containing 100 tablets. The label includes dosage strength, storage instructions, manufacturer details including Cadila Pharmaceuticals Ltd. and Nivagen Pharmaceuticals, toll-free number, NDC number 75834-202-01, and a barcode space for 2D barcode printing.*
FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg Tablet Bottle Label)
Label for Glyburide Tablets, USP 2.5 mg, containing 100 tablets. The label states each tablet contains 2.5 mg glyburide and includes storage instructions, caution notes, and manufacturing details. Manufactured by Cadila Pharmaceuticals Ltd and labeled by Nivagen Pharmaceuticals, Inc. The label also displays the NDC 75834-203-01 and a barcode.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
Label for GlyBURIDE Tablets, USP 5 mg by Nivagen Pharmaceuticals, Inc. The package contains 100 tablets and is labeled Rx only. It includes storage instructions, dispensing warnings, manufacturer details from Nivagen Pharmaceuticals and Cadila Pharmaceuticals Ltd., a barcode, and an issuance date of 01/2019.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.